1992•American Journal of PerinatologyRequires access

In Utero Conversion of Supraventricular Tachycardia with Digoxin and Procainamide at 17 Weeks' Gestation

C E Battiste, Timothy Neff, John J. Evans, Byron Cline

Open publisher page 8 citations

Abstract

The earliest reported case of fetal supraventricular tachycardia at 17 weeks' gestation causing hydrops fetalis is presented. Maternal treatment with digoxin and procainamide successfully cardioverted the fetus with resolution of the hydrops. Using this combination, sinus rhythm was maintained until term.

About this research paper

What this paper is about

The earliest reported case of fetal supraventricular tachycardia at 17 weeks' gestation causing hydrops fetalis is presented. Maternal treatment with digoxin and procainamide successfully cardioverted the fetus with resolution of the hydrops. Using this combination, sinus rhythm was maintained until term.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The earliest reported case of fetal supraventricular tachycardia at 17 weeks' gestation causing hydrops fetalis is presented. Maternal treatment with digoxin and procainamide successfully cardioverted the fetus with resolution of the hydrops. Using this combination, sinus rhythm was maintained until term.

Key concepts: Procainamide, Medicine, Supraventricular tachycardia, Digoxin, Hydrops fetalis, Gestation, Sinus rhythm, In utero

Related papers

Back to paper searchBrowse research topicsOriginal source
In Utero Conversion of Supraventricular Tachycardia with Digoxin and Procainamide at 17 Weeks' Gestation — Research Paper | ScholarLens